光遺傳學市場－全球產業規模、佔有率、趨勢、機會、預測：光源、執行器、感測器、應用、區域及競爭格局，2021-2031年

全球光遺傳學市場預計將從 2025 年的 6.3302 億美元大幅成長至 2031 年的 8.4492 億美元，複合年成長率達到 4.93%。

推動這一成長的主要因素是神經系統疾病日益普遍，預計到2025年，全球將有超過30億人受到此類疾病的影響，以及對神經科學研究的大量投入，這些研究致力於繪製神經迴路圖譜。光遺傳學是一種利用光來控制表達光敏離子通道的基因改造神經元的生物學技術，它為闡明大腦功能和加速治療方法的發現提供了一種至關重要的前沿研究工具。這促使人們迫切需要精準醫療，並推動光遺傳學技術在研究和臨床實踐中的應用。

市場促進因素

光遺傳學市場的主要驅動力是公共和私人對神經科學研發投入的大幅成長，因為這項技術正從臨床前階段發展到應用於人體治療。創業投資和政府資助正在幫助生物技術公司克服與基因轉移和光刺激相關的臨床挑戰。例如，Beacon Therapeutics 於 2024 年 7 月成功獲得 1.7 億美元的資金籌措，用於開發治療 X 連鎖視網膜色素變性的光遺傳學資產；此外，BRAIN舉措在 2024 年撥款 4.02 億美元用於神經技術開發。另一個主要促進因素是光遺傳學在藥物發現和治療方法檢驗的應用日益廣泛。尤其是在眼科領域，光遺傳學已被證明可以透過光敏化視網膜細胞來恢復視力。 Nanoscope Therapeutics 的 MCO-010 療法在 2024 年 10 月取得了臨床成功，其在視力方面展現出統計學意義上的顯著改善，這凸顯了該技術的治療潛力，並推動其在各種中樞神經系統疾病的非臨床藥物篩檢中得到更廣泛的應用。

市場挑戰

全球光遺傳學市場面臨許多重大挑戰。其中包括將光以非侵入性方式傳遞至大腦深層結構的嚴格技術要求，以及用於基因遞送的病毒載體的潛在免疫抗原性。這些複雜性導致需要進行廣泛的臨床前檢驗，以防止不良免疫反應和神經組織損傷，從而延長了人類治療方法的研發週期，增加了研發成本，並延緩了監管核准。難以將成功的動物模型快速轉化為安全的人類療法，限制了市場向臨床治療領域的擴展。此外，日益減少的財政資源加劇了這些技術障礙。例如，預計到2025年，聯邦政府用於「腦舉措）的預算將削減至3.21億美元，這將直接阻礙對開發更安全的病毒載體和侵入性更小的光遞送系統至關重要的先進神經科學項目，從而阻礙市場在提供核准的光遺傳學解決方案方面的進展。

市場趨勢

隨著無線和無電池光遺傳學系統的日益普及，市場格局正在改變。這些系統克服了有線光纖設備的局限性，使得研究人員能夠在自然環境中自由活動，不受物理限制或組織損傷的情況下，研究受試者的複雜行為。這包括將微型發光元件直接整合到植入式探針中。例如，西北大學於2025年12月推出了一款完全植入式、無電池的設備，該設備配備可程式設計微型LED陣列，用於精確控制皮質活動。同時，光遺傳學的應用範圍正從神經系統擴展到心臟和其他非神經組織，為心律不整和聽力障礙等疾病開發精準的干涉手段。這種多樣化是由具有更快反應速度的特異性視蛋白的開發所驅動的，並得到了諸如新型光遺傳學平台等進步的支持。根據美國心臟協會2025年11月報道，該平台在心臟模型中終止誘發性心律不整的成功率達到了100%。這凸顯了該技術在精確心率管理方面的廣泛臨床應用價值。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球光遺傳學市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 透過光源（雷射、發光二極體）
  • 致動器類型（通道視紫質、鹵視紫質、古視紫質）
  • 感測器類型（鈣離子感測器（水母發光蛋白感測器、變色龍感測器和其他鈣離子感測器）、氯化物感測器（鉻變色龍感測器）、電壓依賴型感測器（美人魚感測器）、其他感測器）
  • 依應用領域（神經科學、行為追蹤、視網膜、疾病治療、其他應用）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美光遺傳學市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲光遺傳學市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區光遺傳學市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲光遺傳學市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美光遺傳學市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球光遺傳學市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Cobolt Inc.
• Coherent Inc.
• Gensight Biologics SA
• Laserglow Technologies
• Noldus Information Technology Inc.
• Judges'Scientific PLC
• Shanghai Laser & Optics Century Co. Ltd
• Bruker Corporation
• Thorlabs Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Optogenetics Market is forecast to expand significantly, from USD 633.02 Million in 2025 to USD 844.92 Million by 2031, achieving a Compound Annual Growth Rate of 4.93%. This growth is primarily driven by the increasing incidence of neurological disorders, which affected over three billion people worldwide in 2025, and substantial investments in neuroscience research focused on mapping neural circuits. Optogenetics, a biological method employing light to control genetically modified neurons expressing light-sensitive ion channels, provides crucial advanced research tools to understand brain function and accelerate therapeutic discoveries, thereby supporting the urgent demand for precision medicine and the adoption of optogenetic technologies in research and clinical environments.

Market Driver

The optogenetics market is primarily driven by a significant increase in public and private investment in neuroscience research and development, as the technology progresses from preclinical stages to potential human therapeutics. Venture capital and government funding are supporting biotechnology firms to overcome clinical challenges related to gene delivery and light stimulation, exemplified by Beacon Therapeutics securing $170 million in July 2024 for an optogenetic asset for X-linked retinitis pigmentosa, alongside the BRAIN Initiative's $402 million allocation in 2024 for neurotechnology development. A second key driver is the expanding application of optogenetics in drug discovery and therapeutic validation, particularly within ophthalmology, where it has shown effectiveness in restoring vision by photosensitizing retinal cells. Clinical successes, such as Nanoscope Therapeutics' MCO-010 therapy demonstrating statistically significant improvements in visual acuity in October 2024, validate the technology's therapeutic potential and encourage its broader adoption in preclinical drug screening for various central nervous system conditions.

Market Challenge

Significant challenges constrain the Global Optogenetics Market, notably the rigorous technical demands for non-invasively delivering light to deep brain structures and the potential immunogenicity of viral vectors used for gene delivery. These complexities necessitate extensive preclinical validation to prevent harmful immune responses or neural tissue damage, which prolongs development timelines for human therapies, increases R&D costs, and slows regulatory approvals. This difficulty in rapidly translating successful animal models into safe human treatments restricts the market's expansion into clinical therapeutics. Furthermore, these technical barriers are exacerbated by declining financial resources, as illustrated by the BRAIN Initiative's federal budget being reduced to $321 million in 2025, directly impeding advanced neuroscience programs crucial for developing safer viral vectors and less invasive light-delivery systems, thereby hindering the market's progress in delivering approved optogenetic solutions.

Market Trends

The market is being transformed by the increasing adoption of wireless and battery-free optogenetic systems, which overcome the limitations of tethered fiber-optic setups by enabling the study of complex behaviors in freely moving subjects within naturalistic environments, free from physical restrictions or tissue damage. This involves integrating miniaturized light-emitting components directly into implantable probes, as exemplified by Northwestern University's December 2025 introduction of a fully implantable, battery-free device with a programmable micro-LED array for precise cortical activity control. Concurrently, optogenetics is expanding beyond central nervous system applications into cardiac and other non-neuronal tissues, developing precision interventions for conditions such as arrhythmias and auditory deficits. This diversification, facilitated by the development of specialized opsins with faster kinetics, is validated by advancements like a new optogenetic platform achieving a 100% success rate in terminating induced arrhythmias in cardiac models, as reported by the American Heart Association in November 2025, underscoring the technology's broad translational potential for precise heart rhythm management.

Key Market Players

• Cobolt Inc.
• Coherent Inc.
• Gensight Biologics S.A.
• Laserglow Technologies
• Noldus Information Technology Inc.
• Judges' Scientific PLC
• Shanghai Laser & Optics Century Co. Ltd
• Bruker Corporation
• Thorlabs Inc.

Report Scope

In this report, the Global Optogenetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Optogenetics Market, By Light Equipment

• Laser
• Light-emitting Diode

Optogenetics Market, By Actuator

• Channelrhodopsin
• Halorhodopsin
• Archaerhodopsin

Optogenetics Market, By Sensor

• Calcium
• Chloride (Clomeleon)
• Membrane-gated (Mermaid)
• Other Sensors

Optogenetics Market, By Application

• Neuroscience
• Behavioral Tracking
• Retinal
• Disease Treatment
• Other Applications

Optogenetics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Optogenetics Market.

Available Customizations:

Global Optogenetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Optogenetics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Light Equipment (Laser, Light-emitting Diode)
  • 5.2.2. By Actuator (Channelrhodopsin, Halorhodopsin, Archaerhodopsin)
  • 5.2.3. By Sensor (Calcium (Aequorin, Cameleon, and Other Calcium Sensors), Chloride (Clomeleon), Membrane-gated (Mermaid), Other Sensors)
  • 5.2.4. By Application (Neuroscience, Behavioral Tracking, Retinal, Disease Treatment, Other Applications)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Optogenetics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Light Equipment
  • 6.2.2. By Actuator
  • 6.2.3. By Sensor
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Optogenetics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Light Equipment
      • 6.3.1.2.2. By Actuator
      • 6.3.1.2.3. By Sensor
      • 6.3.1.2.4. By Application
  • 6.3.2. Canada Optogenetics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Light Equipment
      • 6.3.2.2.2. By Actuator
      • 6.3.2.2.3. By Sensor
      • 6.3.2.2.4. By Application
  • 6.3.3. Mexico Optogenetics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Light Equipment
      • 6.3.3.2.2. By Actuator
      • 6.3.3.2.3. By Sensor
      • 6.3.3.2.4. By Application

7. Europe Optogenetics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Light Equipment
  • 7.2.2. By Actuator
  • 7.2.3. By Sensor
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Optogenetics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Light Equipment
      • 7.3.1.2.2. By Actuator
      • 7.3.1.2.3. By Sensor
      • 7.3.1.2.4. By Application
  • 7.3.2. France Optogenetics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Light Equipment
      • 7.3.2.2.2. By Actuator
      • 7.3.2.2.3. By Sensor
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Optogenetics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Light Equipment
      • 7.3.3.2.2. By Actuator
      • 7.3.3.2.3. By Sensor
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Optogenetics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Light Equipment
      • 7.3.4.2.2. By Actuator
      • 7.3.4.2.3. By Sensor
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Optogenetics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Light Equipment
      • 7.3.5.2.2. By Actuator
      • 7.3.5.2.3. By Sensor
      • 7.3.5.2.4. By Application

8. Asia Pacific Optogenetics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Light Equipment
  • 8.2.2. By Actuator
  • 8.2.3. By Sensor
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Optogenetics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Light Equipment
      • 8.3.1.2.2. By Actuator
      • 8.3.1.2.3. By Sensor
      • 8.3.1.2.4. By Application
  • 8.3.2. India Optogenetics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Light Equipment
      • 8.3.2.2.2. By Actuator
      • 8.3.2.2.3. By Sensor
      • 8.3.2.2.4. By Application
  • 8.3.3. Japan Optogenetics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Light Equipment
      • 8.3.3.2.2. By Actuator
      • 8.3.3.2.3. By Sensor
      • 8.3.3.2.4. By Application
  • 8.3.4. South Korea Optogenetics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Light Equipment
      • 8.3.4.2.2. By Actuator
      • 8.3.4.2.3. By Sensor
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Optogenetics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Light Equipment
      • 8.3.5.2.2. By Actuator
      • 8.3.5.2.3. By Sensor
      • 8.3.5.2.4. By Application

9. Middle East & Africa Optogenetics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Light Equipment
  • 9.2.2. By Actuator
  • 9.2.3. By Sensor
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Optogenetics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Light Equipment
      • 9.3.1.2.2. By Actuator
      • 9.3.1.2.3. By Sensor
      • 9.3.1.2.4. By Application
  • 9.3.2. UAE Optogenetics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Light Equipment
      • 9.3.2.2.2. By Actuator
      • 9.3.2.2.3. By Sensor
      • 9.3.2.2.4. By Application
  • 9.3.3. South Africa Optogenetics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Light Equipment
      • 9.3.3.2.2. By Actuator
      • 9.3.3.2.3. By Sensor
      • 9.3.3.2.4. By Application

10. South America Optogenetics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Light Equipment
  • 10.2.2. By Actuator
  • 10.2.3. By Sensor
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Optogenetics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Light Equipment
      • 10.3.1.2.2. By Actuator
      • 10.3.1.2.3. By Sensor
      • 10.3.1.2.4. By Application
  • 10.3.2. Colombia Optogenetics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Light Equipment
      • 10.3.2.2.2. By Actuator
      • 10.3.2.2.3. By Sensor
      • 10.3.2.2.4. By Application
  • 10.3.3. Argentina Optogenetics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Light Equipment
      • 10.3.3.2.2. By Actuator
      • 10.3.3.2.3. By Sensor
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Optogenetics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Cobolt Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Coherent Inc.
• 15.3. Gensight Biologics S.A.
• 15.4. Laserglow Technologies
• 15.5. Noldus Information Technology Inc.
• 15.6. Judges' Scientific PLC
• 15.7. Shanghai Laser & Optics Century Co. Ltd
• 15.8. Bruker Corporation
• 15.9. Thorlabs Inc.

16. Strategic Recommendations

17. About Us & Disclaimer